Hi guys, Welcome to the Advanced Video Search Engine, and you are watching Genomic landscape of late-stage gastric cancer treated with pembrolizumab. That video is uploaded by VJOncology at 2021-10-14T09:21:33-07:00. We are promoting this video only for entertainment and educational purpose only. So, I hope you like & enjoy it. [CWiaGTJ9cYA]
| Name | Genomic landscape of late-stage gastric cancer treated with pembrolizumab |
| Video Uploader | Video From VJOncology |
| Upload Date | This Video Uploaded At 14-10-2021 16:21:33 |
| Video Discription | Yelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the results from a biomarker analysis examining the genomic landscape of late-stage gastric cancer and gastroesophageal junction adenocarcinoma in patients treated with pembrolizumab monotherapy or combined with chemotherapy. The Cancer Genome Atlas (TCGA) defines four categories of gastric cancers: microsatellite instability-high (MSI-H) tumours, Epstein–Barr virus (EBV)-positive tumors, chromosomally unstable tumors and genomically stable tumors. Dr Janjigian explains that their analysis revealed that MSI-H tumors were much rarer than suggested by the TCGA. Similarly, chromosomally unstable tumors are the most common subset in this population and there are no significant differences in tumor biology between patients from east and west Asia. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress. CWiaGTJ9cYA |
| Category | Education |
| Tags | Speaker: Yelena Y. Janjigian | Institution: Memorial Sloan Kettering Cancer Center | Event: ESMO 2021 | Format: Interview | Event: VJVirtual | Subject: Gastric Cancer | Subject: Gastroesophageal Cancer | Subject: Gastrointestinal Cancer | Medicines: Pembrolizumab | Medicines: Antibodies | Field: Molecular Profiling | Field: Disease Biology | Field: Immuno-Oncology | monotherapy | The Cancer Genome Atlas | TCGA | MSI-I | Epstein–Barr virus | EBV |
